The -Catenin Axis Integrates Multiple Signals Downstream from RET/Papillary Thyroid Carcinoma Leading to Cell Proliferation

¹Istituto di Endocrinologia ed Oncologia Sperimentale "G. Salvatore," Consiglio Nazionale delle Ricerche, c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare "L. Califano," Universita Federico II, Naples, Italy; ²Department of Genetics, Institute of Basic Molecular Sciences, University of Madras, Madras, India; ³Division of Pathology, Department of Surgery, University of Pisa, Pisa, Italy; and ⁴National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland

^* To whom correspondence should be addressed. E-mail: masantor{at}unina.it.

	Abstract

RET/papillary thyroid carcinoma (RET/PTC) oncoproteins result from the in-frame fusion of the RET receptor tyrosine kinase domain with protein dimerization motifs encoded by heterologous genes. Here, we show that RET/PTC stimulates the -catenin pathway. By stimulating PI3K/AKT and Ras/extracellular signal–regulated kinase (ERK), RET/PTC promotes glycogen synthase kinase 3 (GSK3) phosphorylation, thereby reducing GSK3-mediated NH₂-terminal -catenin (Ser33/Ser37/Thr41) phosphorylation. In addition, RET/PTC physically interacts with -catenin and increases its phosphotyrosine content. The increased free pool of S/T(nonphospho)/Y(phospho)-catenin is stabilized as a result of the reduced binding affinity for the Axin/GSK3 complex and activates the transcription factor T-cell factor/lymphoid enhancer factor. Moreover, through the ERK pathway, RET/PTC stimulates cyclic AMP–responsive element binding protein (CREB) phosphorylation and promotes the formation of a -catenin-CREB-CREB-binding protein/p300 transcriptional complex. Transcriptional complexes containing -catenin are recruited to the cyclin D1 promoter and a cyclin D1 gene promoter reporter is active in RET/PTC–expressing cells. Silencing of -catenin by small interfering RNA inhibits proliferation of RET/PTC–transformed PC Cl3 thyrocytes, whereas a constitutively active form of -catenin stimulates autonomous proliferation of thyroid cells. Thus, multiple signaling events downstream from RET/PTC converge on -catenin to stimulate cell proliferation. [Cancer Res 2009;69(5):1867–76]

Key Words: thyroid cancer, tyrosine kinase, oncogene

This article has been cited by other articles:

				A. Cerrato, V. De Falco, and M. Santoro Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets J. Mol. Endocrinol., October 1, 2009; 43(4): 143 - 155. [Abstract] [Full Text] [PDF]

				D. S. Richardson, T. S. Gujral, S. Peng, S. L. Asa, and L. M. Mulligan Transcript Level Modulates the Inherent Oncogenicity of RET/PTC Oncoproteins Cancer Res., June 1, 2009; 69(11): 4861 - 4869. [Abstract] [Full Text] [PDF]